Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized placebo-controlled study of desvenlafaxine for vasomotor symptoms in breast cancer survivors
TCTR20210326006Phase 2Active, not recruiting
- Sponsor
- Khon Kaen University
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of desvenlafaxine in vasomotor symptoms, sponsored by Khon Kaen University. Started Mar 2021; status: active, not recruiting.
02
Drugs
desvenlafaxine
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on TCTR20210326006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210326006.